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ABSTRACT Syndecan-2 is a heparan sulfate proteoglycan that has a cell adhesion regulatory 
domain contained within its extracellular core protein. Cell adhesion to the syndecan-2 extra-
cellular domain (S2ED) is β1 integrin dependent; however, syndecan-2 is not an integrin li-
gand. Here the protein tyrosine phosphatase receptor CD148 is shown to be a key intermedi-
ary in cell adhesion to S2ED, with downstream β1 integrin–mediated adhesion and 
cytoskeletal organization. We show that S2ED is a novel ligand for CD148 and identify the 
region proximal to the transmembrane domain of syndecan-2 as the site of interaction with 
CD148. A mechanism for the transduction of the signal from CD148 to β1 integrins is eluci-
dated requiring Src kinase and potential implication of the C2β isoform of phosphatidylinosi-
tol 3 kinase. Our data uncover a novel pathway for β1 integrin–mediated adhesion of impor-
tance in cellular processes such as angiogenesis and inflammation.
INTRODUCTION
Cellular adhesion to the extracellular matrix is an essential feature in 
developmental processes, tissue repair, inflammation, and immune 
surveillance. The principal drivers of these processes are integrins; 
however an important emerging awareness is that cell surface re-
ceptor families such as tetraspanins, receptor tyrosine kinases, and 
growth factor and cytokine receptors can cooperate with integrins 
to modulate cell behavior and cell fate (Streuli and Akhtar, 2009). 
The syndecans are another such family of cell surface receptors that 
function in close association with integrins (Couchman, 2003, 2010). 
Syndecans are a four -member family of heparan sulfate proteogly-
cans with roles in cell adhesion, migration, and growth factor and 
cytokine signaling (for reviews see Alexopoulou et al., 2006; Morgan 
et al., 2007; Okina et al., 2009; Couchman, 2010). Each syndecan 
family member has a distinctive expression profile, and despite re-
gions of sequence homology they have distinct sequence motifs 
suggestive of discrete functionality (Kim et al., 1994). Of relevance 
to this work is syndecan-2, which is expressed principally in fibro-
blasts and cells of the vasculature (Marynen et al., 1989; Essner 
et al., 2006; Fears et al., 2006). Syndecan-2 has roles in left–right 
axis development in Xenopus and also affects branching angiogen-
esis and matrix deposition and assembly in the developing zebrafish 
embryo (Chen et al., 2002; Kramer and Yost, 2002; Arrington and 
Yost, 2009). The effects of syndecan-2 on angiogenesis and matrix 
deposition have also been established in cell culture systems (Klass 
et al., 2000; Galante and Schwarzbauer, 2007; Noguer et al., 2009).
Syndecan-2, like other members of the family, has a short, con-
served cytoplasmic domain consisting of two highly conserved sub-
domains (C1 and C2) that flank a more variable V region. The C-
termini of the membrane distal C2 domain is a canonical PDZ 
binding motif, which, in common with other syndecans, interacts 
with proteins containing PDZ domains such as syntenin, CASK/LIN, 
and GIPC/synectin (Grootjans et al., 1997; Hsueh et al., 1998; Gao 
et al., 2000). The membrane proximal C1 domain of syndecan-2 in-
teracts with the actin-binding protein ezrin and is believed to pro-
vide a link between syndecan-2 and the actin cytoskeleton (Granés 
et al., 2000). Syndecan-2 induces dendritic spine formation in hip-
pocampal neurons, and this depends on phosphorylation of the 
syndecan-2 cytoplasmic domain by the tyrosine kinase receptor 
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EphB (Ethell and Yamaguchi, 1999; Ethell et al., 2001). In colon car-
cinoma cells syndecan-2 expression affects adhesion, proliferation, 
and tumorigenic activity (Contreras et al., 2001; Park et al., 2002; 
Fears et al., 2006).
Many syndecan functions are mediated by interactions with their 
heparan sulfate (HS) chains—for example, the interaction between 
syndecan-4 HS and the heparin-binding domain of fibronectin (FN). 
This interaction, in concert with α5β1 integrin, promotes focal adhe-
sion formation in fibroblasts and depends on syndecan-4 signaling 
(Saoncella et al., 1999; Woods et al., 2000; Couchman, 2003; 
Morgan et al. 2007). However, syndecans can also promote integrin-
mediated cell responses through interactions with regulatory se-
quences contained within their extracellular core protein. The 
syndecan-1 ectodomain interacts directly with both αVβ3 and αVβ5 
integrin (Beauvais et al., 2004, 2009; McQuade et al., 2006), result-
ing in cell spreading of MDA-MB-231 cells when syndecan-1 is clus-
tered by cognate antibodies in cell adhesion assays. In addition, 
blockade of this interaction using a peptide corresponding to resi-
dues 82–130 of the syndecan-1 ectodomain results in reduced an-
giogenesis in murine models (Beauvais et al., 2009). The extracellu-
lar domains of both syndecan-2 (S2ED) and syndecan-4 (S4ED) 
when expressed as glutathione S-transferase (GST) fusion proteins 
support cell attachment and spreading (McFall and Rapraeger, 
1997; McFall and Rapraeger, 1998; Whiteford and Couchman, 2006; 
Whiteford et al., 2007). Cell adhesion to S4ED requires β1 integrins 
and a conserved NXIP motif in the syndecan core protein but 
does not require either endogenous syndecan-4 or heparan sulfate 
(Whiteford and Couchman, 2006; Whiteford et al., 2007).
The NXIP motif is not present within the sequence of S2ED, and 
competition assays with S2ED and S4ED proteins demonstrate that 
the receptor requirements for adhesion to S2ED are distinct from 
those required for adhesion to S4ED (Whiteford et al., 2007). Fibro-
blasts form focal adhesions in response to the syndecan-2 ectodo-
main, but the underlying mechanism remains unclear, other than a 
requirement for Rho small GTPases and Rho kinase (Whiteford et al., 
2007). Integrins are essential for this process since adhesion to the 
syndecan-2 ectodomain was completely ablated by the presence of 
β1 integrin–blocking antibodies. In Jurkat cells, phorbol ester–stim-
ulated adhesion to S2ED is blocked not only with the addition of 
β1-blocking antibodies but also with antibodies specific to the α4 
subunit. The syndecan-2 ectodomain is not a α4β1 integrin–specific 
ligand since many of the cell lines that adhere to S2ED do not pos-
sess the α4 subunit, and direct binding assays using recombinant 
α4β1 in conjunction with S2ED revealed no interaction (Whiteford 
et al., 2007). This led us to speculate that an alternative cell surface 
receptor mediates the interaction between β1 integrins and the syn-
decan-2 ectodomain.
Here we map the adhesion regulatory domain in syndecan-2 and 
identify the syndecan-2 ectodomain as a ligand for the protein ty-
rosine phosphatase receptor CD148. We propose that adhesion to 
this substrate occurs through CD148 signaling to β1 integrin via a 
process involving both dephosphorylation of the p85 subunit of 
phosphatidylinositol 3 kinase (PI3K) and the activity of the class II 
PI3K-C2β in a Src kinase–dependent process.
RESULTS
The adhesion-promoting activity of the syndecan-2 
ectodomain resides in the juxtamembrane region
A GST fusion protein encompassing almost the entire ectodomain 
of syndecan-2 supports cell adhesion, whereas GST alone does not 
(Whiteford et al., 2007). To map which regions of the syndecan-2 
ectodomain regulate cell adhesion, a series of proteins containing 
in-frame deletions within the murine syndecan-2 ectodomain were 
used as substrates in adhesion assays (Figure 1, A and B). Deletion 
of the N-terminal region (from residue E19 to L73) of S2ED containing 
the GAG substitution sites had no effect on fibroblast adhesion, thus 
confirming that the adhesion regulatory domain of syndecan-2 is 
located in an equivalent position to that of syndecan-4 (i.e., between 
the GAG substitution sites and the transmembrane domain) (McFall 
and Rapreager, 1997, 1998). Further deletions within the 69–amino 
acid region of syndecan-2 between Q72 and F141 revealed that cell 
adhesion regulatory activity resides in the C-terminal 18–amino acid 
region including P124 and F141. Mutant syndecan-2 ectodomain fu-
sion proteins in which this region had been deleted (S2EDΔP85-F141, 
S2EDΔP105-F141, and S2EDΔP124-F141) all failed to support fibroblast 
attachment and spreading as reflected by adhesion assays (Figure 1, 
C and D). Fibroblast attachment and spreading were observed only 
in proteins that contained the 18–amino acid P124–F141 region (S2ED, 
S2ED ΔE19-Q72, S2EDΔL73-G123). This was reproducible for Swiss 3T3 
murine fibroblasts, WI38 human lung fibroblasts, primary murine 
lung fibroblasts (Figure 1C), and the leukocytic cell line U937 after 
stimulation with phorbol ester (Supplemental Figure S1A). When 
Swiss 3T3 fibroblasts seeded on either S2ED or S2EDΔL73-G123 were 
processed for fluorescence microscopy, focal adhesion structures 
(vinculin-containing plaques) were observed at the termini of micro-
filament bundles (Figure 1E).
Syndecan ectodomains share little sequence homology be-
tween family members or between the same family members from 
different species. Despite bearing little homology to mammalian 
syndecan-4 ectodomains, the zebrafish syndecan-4 ectodomain 
supports mesenchymal cell attachment and spreading (Whiteford 
and Couchman, 2006; Whiteford et al., 2008). To establish whether 
the adhesion regulatory properties of syndecan-2 were similarly 
conserved, a peptide (S2CBD) based on the 18–amino acid region 
of murine syndecan-2 (P124–F141) containing the adhesion regulatory 
activity was used as a competitor in adhesion assays together with a 
scrambled peptide (S2CBDscr) based on the same sequence. An 
18–amino acid peptide derived from the equivalent part of the ze-
brafish syndecan-2 ectodomain (zebS2CBD; S130–F157) was com-
pared with its mammalian counterpart. Swiss 3T3 fibroblasts were 
incubated in the presence of increasing concentrations of each pep-
tide prior to seeding on wells coated with S2ED. Adhesion was re-
duced in cells coincubated with the murine S2CBD peptide (S2CBD) 
or the corresponding zebrafish peptide (zebS2CBD; S130–F147). The 
scrambled peptide had a negligible effect on cell adhesion even at 
the highest concentrations (Figure 1F). Both mouse and zebrafish 
S2CBD peptides reduced cell adhesion and spreading, and com-
parison of the two peptide sequences revealed that there are con-
siderable similarities in the five C-terminal residues of each peptide 
(Figure 1G). This suggests that the adhesion regulatory properties of 
S2ED are principally driven by these conserved residues, S(E/D)NLF. 
To test this, we also generated a peptide based on S2CBD in which 
the C-terminal four residues DNLF were substituted with AAAA and 
found that it had no inhibitory effect on fibroblast adhesion to S2ED 
(Figure 1F), indicating that these residues are important for the ad-
hesion regulatory properties of the syndecan-2 core protein.
S2ED is a ligand for the protein tyrosine phosphatase 
receptor CD148
Cell adhesion to the ectodomain of syndecan-2 requires β1 integrin. 
However, syndecan-2 is not an integrin ligand, and we could dem-
onstrate no direct interaction between β1 integrins and either S2ED 
or S4ED (Whiteford et al., 2007). Therefore we hypothesized that 
adhesion to the ectodomain of syndecan-2 requires the action of 
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mutants containing this domain (e.g., S2ED ΔE19-Q72 and 
S2EDΔL73-G123) interacted strongly. These data suggest that CD148 
is a key regulator of fibroblast adhesion to S2ED, involving an inter-
action between the extracellular N-terminal part of CD148 and the 
18–amino acid adhesion regulatory motif of S2ED.
CD148 signaling stimulates β1 integrin–dependent cell 
adhesion and spreading
To further dissect the how CD148 promotes fibroblast adhesion, hu-
man lung fibroblasts were seeded on wells coated with murine 
monoclonal CD148-specific antibodies. WI38 fibroblasts attached 
and spread in response to this substrate but failed to attach and 
spread in response to either GST or an isotype control for the CD148 
antibody (Figure 4, A and C). The antibody was confirmed to recog-
nize the N-terminal FNIII repeats 1–5 of CD148 by Western blot of 
bacterial lysates expressing the recombinant domain (Figure 4B). A 
polypeptide of approximately 50 kDa corresponding to FN III re-
peats 1–5 was only evident in bacterial lysates in which expression 
of this protein has been induced. Adhesion to the anti-CD148 anti-
bodies leads to similar cytoskeletal rearrangements in both WI38 
and SW3T3 fibroblasts as that observed in cells adhering to S2ED 
(Figure 4C). Fibroblast adhesion to CD148 antibodies could be 
abolished by the addition of the CD148sf recombinant protein 
(Figure 4D). Moreover, adhesion to the CD148 antibody was depen-
dent on β1 integrin since blockade by the AIIb2 antibody resulted in 
the failure of fibroblasts to attach and spread in response to CD148 
clustering. In contrast, αVβ3 integrin function–blocking antibodies 
had no discernible effect on cell adhesion to CD148 monoclonal 
antibody. These data replicate cell adhesion to S2ED, which was 
also sensitive to inhibition of β1 but not β3 integrin (Whiteford et al., 
2007).
Treatment of cells with phosphatase inhibitors phenylarsine ox-
ide and pervanadate also compromised cell adhesion and cell 
spreading on CD148 antibody substrates, just as they had on S2ED 
substrates (Figure 4D). This indicated the importance of CD148 sig-
naling in promoting adhesion responses. To determine whether 
these β1 integrin–driven processes occur as a result of interactions 
between the extracellular domains of CD148 and β1 integrin on the 
cell surface, we used the recombinant CD148 FN III repeat 1–5 pro-
tein as a substrate in adhesion assays, and no cell lines tested at-
tached or spread in response to this protein (Figure 4E). Further-
more, solid-phase binding assays in which binding of α5β1 integrin 
to FN, S2ED, and CD148sf was measured revealed that only wells 
coated with FN supported β1 integrin binding. No interaction could 
be observed between α5β1 and either S2ED or CD148 (Figure 4F). 
Taken together, these data suggest that the β1 integrin–mediated 
cellular response to CD148 clustering is due to CD148 signaling and 
not interactions between these molecules on the cell surface. These 
data are also consistent with the fact that CD148sf could not com-
promise cell adhesion to FN substrates (Figure 3C).
Epithelial cell adhesion to S2ED is blocked by sialylation
Adhesion to S2ED is a characteristic of cells of a mesenchymal ori-
gin; epithelial cell lines tested fail to interact with this substrate 
(Whiteford et al., 2007). To determine whether posttranslation 
modifications such as N-glycosylation were important for adhesion 
to S2ED, we treated cells with tunicamycin and swainsonine. Tuni-
camycin inhibits the first step in the process of N-glycosylation and 
effectively blocks fibroblast adhesion to S2ED (Figure 5A). Simi-
larly, swainsonine, which affects glycoprotein modifications in the 
Golgi, also had an inhibitory affect on fibroblast adhesion to S2ED 
(Figure 5B); neither treatment suppressed adhesion to FN at the 
another cell surface receptor. Protein phosphorylation is an essential 
mechanism for regulating cellular processes such as cell adhesion 
and involves numerous protein kinases and counteracting protein 
phosphatases. Fibroblasts seeded on S2ED formed focal adhesions 
that stained positive for phosphotyrosine, and we observed in-
creases in the phosphorylation of key focal adhesion components 
such as paxillin and focal adhesion kinase (Whiteford et al., 2007). In 
screens of potential signaling pathways the effect of three common 
protein tyrosine phosphatase inhibitors on adhesion to S2ED was 
assayed. Pervanadate, phenylarsine oxide, and dephostatin bind ir-
reversibly to the catalytic cysteine required for dephosphorylation of 
phosphotyrosine residues (Imoto et al., 1993; Vepa et al., 1997). Ap-
plication of these inhibitors to rat embryonic fibroblasts seeded on 
S2ED resulted in sharply reduced cell attachment and spreading 
(Figure 2A). Adhesion to both S2ED and FN was reduced in the 
presence of these inhibitors. Pervanadate and phenylarsine oxide 
inhibited adhesion to S2ED more efficiently than either sodium va-
nadate or dephostatin. Dephostatin had a greater effect on fibro-
blast adhesion to FN substrates than to S2ED. The importance of 
phosphatase activity to the processes governing adhesion to S2ED 
led us to investigate whether a protein tyrosine phosphatase recep-
tor might be the intermediary molecule that interacts with S2ED 
leading to β1 integrin–dependent cell adhesion and spreading. In a 
small interfering RNA (siRNA) screen of the 207 phosphatase genes 
in the human genome using Jurkat T cell adhesion to S4ED the 
protein tyrosine phosphatase receptor CD148 (PTPRJ/DEP1) was 
identified as being potentially important. This was confirmed for fi-
broblast interactions with S2ED, as WI38 human lung fibroblasts 
transfected with a gene-specific siRNA pair targeted to CD148 had 
significantly reduced adhesion to S2ED (Figure 2, B and C). Trans-
fection of fibroblasts with CD148 siRNAs was confirmed to reduce 
cell surface expression of CD148 by ∼50% (Figure 2D). Down-regu-
lation of CD148 in lung fibroblasts had no effect on cell adhesion in 
response to FN, and transfection of control siRNAs had no effect on 
adhesion to either S2ED or FN (Figure 2C). U937 cells, which also 
adhere to S2ED after phorbol ester stimulation, were shown by flu-
orescence-activated cell sorting (FACS) analysis to express CD148 
(Supplemental Figure S1B).
CD148 is a single-pass, membrane-spanning receptor consisting 
of a single cytoplasmic phosphatase domain and an extracellular 
domain consisting of eight type III FN repeats (Figure 3A). The ex-
tracellular core protein of the human form contains 33 putative sites 
of N-glycosylation, and a splice variant whose mRNA encodes the 
first five N-terminal FN type III repeats is present in the sequence 
databases. The first five FN type III repeats of CD148 were ex-
pressed and purified as recombinant protein (Figure 3B). This re-
combinant protein (CD148sf) was used in several assays. Fibroblast 
adhesion to S2ED was compromised in a dose-dependent manner 
by the presence of soluble CD148sf, with concentrations as low as 
10 μg/ml being effective (Figure 3C). Adhesion to FN was not af-
fected by CD148sf at any concentration used, and cell adhesion to 
S4ED substrates was also largely unaffected, except for a small re-
duction at the highest CD148sf concentration (Figure 3C). Primary 
rat lung fibroblast adhesion to S2ED was also inhibited in the pres-
ence of CD148sf and the adhesion regulatory peptide S2CBD, indi-
cating that this interaction is also relevant to primary cells (Figure 
3D). Solid-phase binding assays on plates coated with S2ED, S4ED, 
the various S2ED deletion mutants, or GST alone revealed a direct 
interaction between CD148sf and S2ED but not S4ED or GST. Con-
sistent with the cell adhesion data shown in Figure 1, the S2ED dele-
tion mutants lacking the 18–amino acid adhesion regulatory domain 
between P124 and F141 also showed no binding to CD148sf, whereas 
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FiguRE 1: The adhesion regulatory properties of the syndecan-2 extracellular core protein reside between P124 and 
F141. Schematic diagram of the mutated forms of S2ED proteins (A) and the purified proteins resolved by SDS–PAGE 
and stained with Coomassie brilliant blue (B). (C) Wells were coated with each form of S2ED and seeded with either 
Swiss 3T3 (dark gray bars) or WI38 human lung fibroblasts (light gray bars) or primary murine lung fibroblasts (white 
bars) in serum-free media. Cell adhesion was measured after 60 min of incubation, and percentage adhesion was 
calculated relative to adhesion to S2ED, set at 100%. Error bars represent the SD of absorbance measurements made 
from four separate wells. (D) Phase-contrast micrographs of Swiss 3T3 fibroblasts seeded in serum-free media onto 
wells coated with each form of S2ED and captured after 60 min (scale bar, 50 μm). Only forms of S2ED that contain the 
18–amino acid region of S2ED between Pro124 and Phe141 support fibroblast attachment and spreading (namely S2ED, 
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concentrations used. Several molecular interactions are blocked 
by terminal sialylation of cell surface receptors, and an example is 
the lymphatic endothelial hyaluronan receptor LYVE-1. When ex-
pressed in certain cell types LYVE-1 is incapable of ligand binding, 
and it is only after treatment with the acetyl-neuraminyl hydrolase 
neuraminidase that ligand binding occurs (Nightingale et al., 
2009). To test whether epithelial cell adhesion to S2ED could be 
stimulated in epithelial cell lines by the removal of N-acetyl-
neuraminic acid residues, we treated MDCK cells with neuramini-
dase. Untreated MDCK cells fail to adhere to S2ED; however, sig-
nificant attachment and cell spreading occurred in cells treated 
with this enzyme (Figure 5, C and D). This was also true of the 
mouse ovarian surface epithelial cell line ID8 and HEK293 cells, 
which, when treated with neuraminidase, also became adherent to 
S2ED (Figure 5E and Supplemental Figure S2). However, neuramin-
idase-treated HEK293 adhesion to S2ED could be inhibited by the 
addition of the adhesion regulatory peptide (S2CBD), the extracel-
lular portion of CD148 (CD148sf), and blockade of β1 integrin, 
suggesting that a similar adhesion regulatory pathway exists in 
epithelial cells but is blocked by sialylation of CD148 (Figure 5E).
Adhesion to S2ED requires Src and Pi3K
Proposed substrates for CD148 include Src kinase and PI3K (Pera 
et al., 2005; Tsuboi et al., 2008). Treatment of fibroblasts with the 
kinase inhibitors PPI, SU6656, and SrcKI resulted in a reduction in 
adhesion to S2ED, anti-CD148 antibodies, and FN. However, SrcKI 
more effectively inhibited adhesion to S2ED than to FN (Figure 6A). 
These three compounds are known inhibitors of Src kinase activity 
but also have effects on other key signaling molecules. To further 
investigate the role of Src kinases in CD148-driven adhesion to 
S2ED, we performed adhesion assays with mouse embryonic fibro-
blasts that are null for the Src family kinases Src, Yes, and Fyn (SYF). 
SYF cells failed to adhere to S2ED, wells coated with anti-CD148 
antibodies, or GST but attached and spread in response to FN 
(Figure 6, B and C). Attachment to S2ED and anti-CD148 antibodies 
was restored in SYF cells in which Src had been reexpressed (SYF + 
Src; Figure 6, B and C). To determine whether the failure of SYF cells 
to attach and spread in response to S2ED or anti-CD148 antibodies 
was due to the absence of CD148, FACS analysis on both SYF and 
SYF + Src cells was performed. For both cell types, CD148 expres-
sion could be demonstrated on the cell surface. Transient transfec-
tion of SYF cells with constructs expressing murine Src, Yes, and Fyn 
showed that only Src kinase could restore the adhesion pathway to 
S2ED (Supplemental Figure S3). These data suggest a role for Src 
kinase in CD148-mediated fibroblast attachment and spreading in 
response to S2ED. Reports suggested that the C-terminal Tyr-527 of 
Src kinase is a substrate for CD148 (Pera et al., 2005). However, 
immunoprecipitations from SYF + Src cells showed no change in 
Tyr527 phosphorylation levels during adhesion to S2ED (Supple-
mental Figure S4).
The p85 subunit of PI3K is a proposed substrate of CD148 
(Tsuboi et al., 2008). To test the involvement of PI3K, adhesion as-
says on WI38 and SYF + Src were performed in the presence of the 
PI3K inhibitor wortmannin (Arcaro and Wymann, 1993). Adhesion to 
S2ED or anti-CD148 antibodies was prevented by wortmannin in 
the two cell lines (Figure 7A; WI38 fibroblast data, Supplemental 
Figure S5). These data suggest a role for PI3K in CD148-mediated 
adhesion to S2ED, most likely downstream of Src kinase. Immuno-
precipitation experiments to establish tyrosine phosphorylation lev-
els of the p85 regulatory subunit of PI3K revealed that it is dephos-
phorylated after 5 min in SYF + Src cells seeded on S2ED. In contrast, 
in cells seeded on FN, p85 phosphorylation levels remain un-
changed (Figure 7B). Phosphorylation of the p85 subunit of PI3K has 
been associated with enhanced PI3K activity, and dephosphoryla-
tion of p85 could therefore have the opposite effect (Cuevas et al., 
2001). Class Ia PI3Ks are heterodimers consisting of a p85 subunit 
and a p110 catalytic subunit. To determine whether changes in the 
phosphorylation of the p85 subunit affected PI3K activity, we im-
munoprecipitated p85-associated PI3K complexes from SYF + Src 
cell lysates at different time points during adhesion to either S2ED 
or FN and tested for PI3K activity. The level of class Ia PI3K activity 
was found to be constant on both substrates at all time points tested 
(Figure 7C). This suggested that during CD148-mediated adhesion 
to S2ED, tyrosine phosphorylation of the p85 subunit of PI3K was 
reduced without down-regulation of its associated kinase activity. 
Mammals have eight isoforms of PI3K, divided into three classes 
(Vanhaesebroeck et al., 2010). Wortmannin is a broad-spectrum 
PI3K inhibitor that affects nearly all members of the PI3K family, with 
the concentrations used in our assays being in excess of the known 
IC50 values for these kinases (Supplemental Table S1; Chaussade 
et al., 2007). Given that the class II PI3K isoform PI3K-C2α is not in-
hibited by wortmannin at the concentrations used (0.01–0.5 μm) 
(Domin et al., 1997), this PI3K can be excluded as being involved in 
S2ED-mediated adhesion. To determine whether other PI3K family 
members were involved in adhesion to S2ED, we tested a second 
PI3K inhibitor, GDC-0941 (Folkes et al., 2008). This inhibitor has IC50 
values of ∼0.003 and ∼0.67 μM for the class I PI3Ks and PI3K-C2β, 
respectively, with substantially higher IC50 for class III PI3Ks (Supple-
mental Table S1; Folkes et al., 2008). SYF + Src cell adhesion to 
S2ED was compromised significantly by the presence of ≥1 μM 
GDC-0941, whereas adhesion to FN was unaffected. Of importance, 
lower concentrations of this inhibitor, in the dose range that is 
S2EDΔE19-Q72, and S2EDΔL73-G123). (E) This adhesion regulatory region also stimulates focal adhesion formation in 
fibroblasts. Swiss 3T3 fibroblasts were seeded onto glass coverslips coated with either S2ED or S2EDΔL73-G123 as 
indicated, fixed, and stained for the focal adhesion component vinculin (green) and F-actin (red) after 60 min of 
incubation. Both substrates stimulate focal adhesion formation (denoted by arrows; scale bar, 50 μm). Fibroblast 
adhesion to S2ED is reduced in the presence of peptides corresponding to murine S2ED (P124–F141) and zebrafish S2ED 
(S130–F147). (F) Swiss 3T3 fibroblasts were seeded on wells coated with S2ED in the presence of peptides (sequences 
below graph) corresponding to murine syndecan-2 P124–F141 (S2CBD), a scrambled peptide based on this sequence 
(S2CBDscr), a peptide based on the murine syndecan-2 P124–F141 peptide in which the terminal four residues (D138–F141) 
are substituted with four alanine residues (S2CBDala), and a peptide corresponding to the equivalent region of zebrafish 
syndecan-2 at the concentrations indicated. Cell adhesion was measured after 60 min of incubation, and adhesion to 
S2ED in the absence of peptide was set at 100%. Error bars represent the SD of absorbance measurements made from 
six replicates. Both murine and zebrafish peptides inhibit cell adhesion to S2ED, whereas the scrambled control and the 
peptide in which the last four C-terminal residues have been substituted with alanine residues have no effect on cell 
adhesion. (G) Sequence alignments of the syndecan-2 adhesion regulatory domains (highlighted) from several 
vertebrates reveal few conserved amino acid residues between murine and zebrafish sequences, except for the 
adhesion regulatory C-terminal SD/ENLF motif.
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FiguRE 2: Adhesion to S2ED requires the protein tyrosine phosphatase receptor CD148. (A) Protein tyrosine 
phosphatase inhibitors compromise cell adhesion to the syndecan-2 ectodomain. Rat embryo fibroblasts were seeded in 
serum-free conditions onto wells coated with either S2ED (dark gray bars) or FN (white bars) as indicated for 60 min in 
the presence of vanadate (V), pervanadate (PV), phenylarsine oxide (PLO), or dephostatin (Deph). Adhesion is shown 
relative to cell adhesion to FN and S2ED in the absence of inhibitors, and error bars represent the SD of mean values of 
four replicates. (B, C) WI38 lung fibroblasts were transfected with a pair of gene-specific CD148 siRNAs at the 
concentrations indicated (B) or control siRNAs (C) and seeded in serum-free media on wells coated with S2ED (dark gray 
bars) or FN (white bars). In C, cells were also seeded on wells coated with GST alone (light gray bars). Cells transfected 
with CD148 siRNAs show reduced adhesion to S2ED compared with control siRNA-transfected cells. Adhesion to FN is 
unaffected by CD148 siRNAs. Adhesion of control siRNA cells seeded on FN substrates was set at 100%. Error bars 
represent the SD of absorbance measurements made from triplicates. (D) Knockdown of CD148 in transfected 
fibroblasts was verified by FACS, which showed a reduction in cell surface CD148 expression. Bar chart indicates the 
median fluorescence intensity of populations of cells immunostained with CD148 specific antibodies.
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expected to block class I PI3Ks (0.01–0.1 μM; Supplemental Table 
S1) had little effect on adhesion to S2ED, suggesting that an addi-
tional PI3K is required for adhesion to S2ED. Inhibition was observed 
at higher concentrations of the inhibitor (≥1 μM), indicating a possi-
ble requirement for the PI3K-C2β isoform of class II PI3K. Alterna-
tively, it is possible that both class I PI3Ks and PI3K-2β need to be 
FiguRE 3: The extracellular domain of CD148 interacts with S2ED. (A) Schematic diagram of CD148 showing the 
extracellular domain comprising eight FNIII repeats, a single transmembrane domain, and a cytoplasmic domain. The 
first five N-terminal FNIII repeats were cloned and expressed in E. coli, and the resultant protein is referred to as 
CD148sf. (B) Purified CD148sf is shown by SDS–PAGE and Coomassie brilliant blue staining. (C) Incubation of Swiss 3T3 
fibroblasts in the presence of CD148sf results in compromised cell adhesion to S2ED. Cells were seeded in serum-free 
media on wells coated with FN, S2ED, S4ED, or GST in the presence of the indicated concentrations of CD148sf. 
Adhesion is calculated relative to adhesion to FN in the absence of CD148sf. (D) Adhesion to S2ED by primary rat lung 
fibroblasts also depends on CD148. Cells were seeded on wells coated with S2ED in serum-free media in the presence 
of CD148sf, the adhesion regulatory peptide S2CBD, and the negative control S2CBDala at the concentrations 
indicated. Adhesion is calculated relative to adhesion to S2ED in the absence of competitors. (E) Direct interactions 
between CD148sf and S2ED are mediated through the adhesion regulatory domain of S2ED. Solid-phase binding assays 
were performed with wells coated with 200 ng of the substrates indicated and incubated in the presence of increasing 
concentrations of CD148sf as indicated. The amount of bound CD148sf was quantified using antibodies specific for 
CD148. CD148sf interacts only with S2ED, S2EDΔE19-Q72, and S2EDΔL73-G123, all of which contain the syndecan-2 
adhesion regulatory motif.
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FiguRE 4: Clustering of CD148 with cognate antibodies results in β1 integrin–dependent cell 
attachment and spreading and requires CD148 signaling. (A) Fibroblasts attached and spread in 
response to clustering with anti-CD148 antibodies. WI38 lung fibroblasts were seeded in 
serum-free media on wells coated with S2ED, GST, an anti–human CD148 antibody, or the 
corresponding murine IgG1κ isotype control. Pronounced adhesion to the S2ED and CD148 
antibody is shown. (B) The anti-CD148 antibody specifically recognizes CD148sf, confirming its 
specificity. Western blot of bacterial lysates from cultures incubated with or without IPTG. The 
antibody recognizes only CD148sf. (C) Adhesion to anti-CD148 antibodies promotes changes in 
cytoskeletal organization in WI38 and Swiss 3T3 fibroblasts Cells were seeded on coverslips 
coated with the substrates indicated in serum-free media and were fixed and stained for F-actin 
after 60 min (scale bar, 50 μm). (D) Fibroblast adhesion and spreading in response to CD148 
inhibited to block adhesion to S2ED. Exper-
iments using Src inhibitors, wortmannin, and 
GDC-0941 also showed that there is a re-
quirement for Src and the PI3K isoforms in 
primary mouse lung fibroblast adhesion to 
S2ED (Supplemental Figure S6).
To determine whether the requirement 
for Src kinase activity occurs upstream or 
downstream of the requirement for PI3K ac-
tivity during adhesion to S2ED, we trans-
fected SYF cells with either wild-type or con-
stitutively active avian Src and treated the 
cells with the PI3K activity inhibitors wort-
mannin and GDC-0941. SYF cells trans-
fected with vector control, wild-type Src, or 
Src (Y527-F) all attached and spread to fi-
bronectin, and the administration of wort-
mannin or GDC-0941 had little effect 
(Figure 7F). Adhesion to S2ED by SYF cells 
is restored by the expression of Src and con-
stitutively active Src (Y527-F) but abolished 
by the addition of wortmannin and GDC-
0941 (Figure 7E). This suggests that acti-
vated Src is required for adhesion to S2ED 
upstream of the requirement for PI3K.
DISCUSSION
The adhesion regulatory property of synde-
can ectodomains in concert with integrins 
is mostly associated with syndecan-1 and 
antibodies requires β1 integrin and protein 
tyrosine phosphatase activity. Fibroblasts 
were seeded on wells coated with anti-CD148 
antibodies in serum-free media in the 
presence of CD148sf (20 μg/ml), β1 integrin 
function–blocking antibodies (AIIb2), αVβ3 
integrin function–blocking antibodies (LM609), 
or the phosphatase inhibitors pervanadate 
(PV) and phenylarsine oxide (PLO) as 
indicated. Blockade of β1 integrin and protein 
tyrosine phosphatase inhibitors results in 
compromised fibroblast adhesion. 
(E) CD148sf does not support human lung 
fibroblast adhesion, indicating that it is not a 
ligand for β1 integrin. Fibroblasts were 
seeded as described on FN, S2ED ,or 
increasing amounts of CD148sf. Cells failed to 
attach and spread in response to CD148sf, 
regardless of concentration. Adhesion of cells 
seeded on S2ED in A, on anti-CD148 
antibodies with no treatment in D, and to FN 
in E was set to 100% in each case. Error bars 
represent the SD of absorbance 
measurements made from five replicates. 
Recombinant α5β1 integrin does not interact 
with CD148sf in solid-phase binding assays 
(F). Assays were performed in 96-well plates 
coated with FN, CD148sf, or S2ED at the 
concentrations indicated. The recombinant 
integrin interacted with FN in a dose-
dependent manner. CD148sf coating was 
verified using anti-CD148 antibodies as 
indicated.
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syndecan-4 (Beauvais et al., 2004, 2009; Whiteford and Couchman, 
2006). However, earlier work showed that S2ED can support mesen-
chymal cell adhesion in a β1 integrin–dependent process, and when 
added to microvascular endothelial cells the syndecan-2 core pro-
tein promoted cell migration and angiogenic sprouting (Fears et al. 
2006; Whiteford et al., 2007). Direct interactions between αVβ3 
FiguRE 5: Adhesion to S2ED is blocked by sialylation of cell surface receptors. Inhibitors of N-glycosylation, such as 
tunicamycin (A) and swainsonine (B), block rat embryo fibroblast cell adhesion to S2ED. Fibroblasts were seeded on 
wells coated with either FN (dark gray bars) or S2ED (light gray bars) for 60 min in the presence of either tunicamycin or 
swainsonine at the concentrations indicated. Adhesion is shown relative to cell adhesion to FN and S2ED in the absence 
of inhibitors, and error bars represent the SD of mean values of four replicates. Epithelial cells adhere to S2ED after 
treatment with neuraminidase (C). MDCK cells were seeded in serum-free media in the presence or absence of 
neuraminidase (500 U). Cells were incubated for 15 min at 37°C prior to seeding on wells coated with either FN (dark 
gray bars) or S2ED (light gray bars). Adhesion is shown relative to cell adhesion for untreated cells seeded on FN, and 
error bars are calculated as described in A and B. Phase-contrast micrographs of MDCK cells seeded on the substrates 
treated with either PBS or neuraminidase. Removal of sialic acid groups results in cell attachment and spreading. Scale 
bar, 50 μM. (E) HEK293 cells adhere to S2ED after treatment with neuraminidase, and the process is inhibited by 
S2CBD, CD148sf, and β1 integrin–blocking antibodies. Cells were seeded on the substrates indicated in serum-free 
media supplemented with neuraminidase and the S2 adhesion regulatory peptide S2CBD (25 μg/ml), CD148sf 
(20 μg/ml), or the β1 integrin–blocking antibody AIIb2 (10 μg/ml). Adhesion is calculated as a percentage of total cell 
adhesion to FN. Error bars represent the SD of five measurements.
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or αVβ5 integrin and the syndecan-1 extracellular core protein 
have been demonstrated (Beauvais et al., 2009); however, a similar 
interaction between syndecan-2 and β1 integrin does not occur 
(Whiteford et al. 2007).
Here we report that adhesion and cytoskeletal organization in 
response to the extracellular core protein of syndecan-2 require 
both an interaction with the protein tyrosine phosphatase receptor 
CD148 and its phosphatase-initiated signaling to promote β1 inte-
grin–mediated fibroblast attachment and spreading (Figure 8). In 
responsive mesenchymal cells, syndecan-2 core protein is a ligand 
for CD148, which until now was an orphan receptor. Engagement 
of CD148 with S2ED and its C-terminal regulatory 18–amino acid 
region promoted a signaling pathway leading to inside-out integ-
rin activation and focal adhesion formation. In fibroblasts, CD148 
was originally identified as density-enhanced phosphatase (DEP1) 
since it was significantly upregulated in cells at confluency (Ostman 
et al., 1994). In-trans interactions between syndecan-2 and CD148 
may stimulate cell adhesion and focal adhesion formation as a 
mechanism to regulate cell proliferation and growth, perhaps con-
sistent with the fact that CD148 has been identified as a tumor 
suppressor (Keane et al., 1996; Ruivenkamp et al., 2002; Iuliano 
et al. 2004). However, CD148 null mice grow and reproduce nor-
mally, are fertile, and show no enhanced susceptibility to tumor 
development (Trapasso et al., 2006). In epithelial cells, CD148 
FiguRE 6: Adhesion to S2ED through CD148 requires Src kinase activity. (A) Treatment of rat embryo fibroblasts with 
the protein kinase inhibitors SU6656, PPI, and SrcKI results in compromised adhesion to S2ED (gray bars), CD148-
specific antibodies (white bars), and FN (black bars). Fibroblasts were seeded onto the substrates in serum-free media 
for 60 min prior to quantification of adhesion. Adhesion in the absence of inhibitors was set at 100%. (B, C) Cells null for 
the Src family kinases Src, Yes, and Fyn (SYF; gray bars) adhere and spread (C) poorly on S2ED and anti-CD148 
antibodies, but these properties are restored by the reexpression of Src in these cells (SYF + Src; white bars). For each 
cell line adhesion to FN was set at 100%. In A and B error bars represent the SD derived from measurements of five 
replicates. Phase-contrast micrographs of SYF and SYF + Src cells seeded on the substrates indicated are shown in 
C (scale bar, 50 μm). (D) Both SYF and SYF + Src cells express CD148 as demonstrated by flow cytometry. Cells stained 
with CD148 antibodies are denoted by black lines and the IgG controls by gray lines.
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FiguRE 7: Adhesion to S2ED via CD148 requires PI3K activity downstream of Src kinase. (A). SYF + Src cells were 
seeded in the presence of the indicated concentrations of the PI3K inhibitor wortmannin on FN- (gray bars), S2ED- 
(white bars), or anti-CD148–coated wells. Adhesion in serum-free conditions for 60 min was quantified. Error bars 
represent the SD from values obtained from four separate wells per condition. (B). The p85 subunit of PI3K is 
dephosphorylated early during adhesion to S2ED. The p85 subunit of PI3K was immunoprecipitated from SYF + Src cell 
lysates harvested at the time points indicated after seeding on either FN or S2ED. Immunoprecipitates were blotted 
and probed with phosphotyrosine antibodies as indicated. (C) The activity of class Ia PI3K heterodimers remains 
constant during adhesion to S2ED (top). PI3K complexes were immunoprecipitated using p85-specific antibodies and 
used in enzyme assays in which phosphatidylinositol 3-phosphate synthesis was measured by incorporation of 32P-Pi. 
Thin-layer chromatograms of PI3K reactions were visualized by autoradiography. As a loading control, the levels of p85 
in each reaction were analyzed by Western blot (bottom). (D) Potential requirement for the class II PI3K-C2β in fibroblast 
adhesion to S2ED. SYF + Src cells were seeded in the presence of the PI3K inhibitor GDC-0941 at the concentrations 
indicated. Adhesion to S2ED was compromised at 1 μM GDC-0941, indicative of PI3K-C2β inhibition (Supplemental 
Table S1). GDC-0941 inhibits class I PI3Ks at much lower concentrations. Adhesion to FN is unaffected at any 
concentration of GDC-0941. Adhesion to S2ED in the presence of dimethyl sulfoxide (DMSO) is set at 100%. The 
activities of PI3K isoforms (based on IC50 data; Supplemental Table S1) at the concentrations of wortmannin and 
GDC-0941 used are as indicated in A and D. PI3K-C2β activity is required downstream of Src activation during SYF cell 
adhesion to S2ED. SYF cells were transfected with either wild-type Src (gray bars), a constitutively active form of Src 
(Y527-F) (white bars) cloned into a bicistronic expression cassette upstream of eGFP, and an empty vector control (black 
bars). Transfected cells were seeded for 1 h at 37°C in serum-free media on wells coated with either S2ED (E) or FN (F). 
Cells were treated with DMSO, 0.01 μM wortmannin, or 1.0 μM GDC-0941 as described. Adherent eGFP-expressing 
cells were counted in fields at 10× magnification. Data are the mean of five separate fields ± SD.
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similar to the NXIP motif important for ad-
hesion to S4ED (Whiteford and Couchman, 
2006). Neither is it similar to the AVAAV 
motif or the region corresponding to the 
bioactive synstatin peptide in the extracel-
lular domain of syndecan-1 (Langford et al., 
2005; Beauvais et al. 2009). The positions 
of these regulatory regions in syndecan-1, 
-2, and -4 in relation to each other are also 
highly variable. The P124–F141 region of syn-
decan-2 is proximal to the transmembrane 
domain, whereas in syndecan-4, NXIP re-
sides further toward the N-terminus of the 
mature protein but C-terminal of the GAG 
substitution sites. The syndecan-1 ectodo-
main is much larger than either syndecan-2 
or -4 and, in common with syndecan-3, has 
potential GAG substitution sites situated 
close to the transmembrane domain. The 
body of work relating to the adhesion regu-
latory properties of syndecan-1, -2, and -4 
strongly suggests that this is a property of 
all syndecans. However, the syndecan-3 
ectodomain differs in having a mucin ho-
mology domain that may be heavily O-gly-
cosylated, which might affect such interac-
tions (Carey, 1996). Syndecans are obligate 
dimers, and this is primarily driven by inter-
actions within syndecan transmembrane 
domains (Choi et al., 2005). It is possible 
that the regulatory sequences identified 
have major structural significance and also 
regulate dimer formation.
Adhesion to the ectodomain of syndecan-4 is conserved in fish, 
and we demonstrated here that this applies to syndecan-2. Whether 
adhesion regulatory domains exist on syndecans from more ancient 
animals (e.g., Ciona) has yet to be established. However, interaction 
between the Drosophila syndecan and the protein tyrosine phos-
phatase receptor LAR was reported, and this affects synaptic devel-
opment (Fox and Zinn, 2005; Johnson et al., 2006). However, this 
interaction requires HS from the Drosophila syndecan, and whether 
direct interactions occur between the two receptors’ protein ect-
odomains is not known. CD148 belongs to a family distinct from 
LAR, possessing a single phosphatase domain, compared with the 
tandem catalytic domain of LAR.
The lack of similarity in protein sequence between the synde-
can-2 and -4 adhesion-promoting motifs suggests that receptor re-
quirements are specific for adhesion to each protein. Adhesion to 
S2ED cannot be compromised in competition assays by recombi-
nant S4ED (Whiteford et al., 2007). An initial siRNA array screen of 
207 phosphatase genes identified CD148 as being required for 
phorbol ester–stimulated leukocyte adhesion to S4ED. However, in 
this study we could show no direct interaction between the N-termi-
nal five FNIII repeats of CD148 and S4ED despite a strong interac-
tion with S2ED. Mature CD148 is heavily N-glycosylated, and we 
show the importance of these moieties in differentiating between 
the adhesive characteristics of mesenchymal cells and epithelial 
cells with regard to cell adhesion to S2ED.
A number of putative PTPRJ substrates have been identified us-
ing substrate trapping and overexpression methodologies, includ-
ing c-Src, PI3K, platelet-derived growth factor receptor, hepatocyte 
growth factor receptor (cMet), and p120 catenin (Kovalenko et al., 
localizes to cell–cell contacts and dephosphorylates the tight-
junction proteins occludin and ZO-1 (Sallee and Burridge, 2009). 
However, tight junctions are not a feature of fibroblasts.
Syndecan-2 null mice have yet to be generated; however, ani-
mal models and expression data suggest roles for syndecan-2 in 
the vasculature, as is also the case for CD148. CD148 null mice 
have an increased tendency for bleeding and arterial thrombosis, 
and, as the only PTPR expressed in platelets, CD148 may be a 
regulator of platelet activation (Senis et al., 2009). Mice expressing 
a catalytically dead form of CD148 in which the cytoplasmic do-
main has been substituted die in midgestation due to chronic vas-
cularization failure (Takahashi et al., 2003). Furthermore, roles for 
zebrafish CD148 in arterial/venous cell fate have been established, 
and CD148 is important for endothelial cell survival (Rodriguez 
et al., 2008; Chabot et al., 2009). Syndecan-2 is closely associated 
with matrix deposition (Klass et al., 2000; Galante and Schwarz-
bauer, 2007), although both the HS chains and the syndecan-2 
cytoplasmic domain are required for this process. Focal adhesions 
are also sites of matrix deposition and remodeling, and fibroblasts 
form focal adhesions in response to S2ED. This interaction may 
also play a role in syndecan-2–mediated matrix deposition, and 
since syndecans are readily shed by numerous proteinases, matrix-
associated syndecan-2 may promote the adhesion pathway de-
scribed here.
Syndecan-family ectodomain sequences bear little homology 
to each other, and the putative adhesion regulatory motif of S2ED 
is not homologous with adhesion-promoting sequences identified 
in syndecan-1 and -4. The 18–amino acid region lying between 
P124 and F141 of murine syndecan-2 does not contain sequence 
FiguRE 8: The extracellular core protein of syndecan-2 promotes β1 integrin–mediated cell 
adhesion through interactions with CD148. Schematic model of the interaction between 
adhesion regulatory elements in the syndecan-2 ectodomain and the protein tyrosine 
phosphatase receptor CD148 leading to the dephosphorylation of the p85 subunit of PI3K. 
The interaction requires the action of both Src kinase and PI3K-C2β.
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CD148 in integrin-mediated cell adhesion and suggests that in ad-
dition to classic integrin–ligand interactions, other receptors can in-
fluence integrin activity status.
MATERIALS AND METHODS
Antibodies and synthetic peptides
The following antibodies were used in this study: β1 integrin func-
tion–blocking antibodies AIIb2 (a kind gift from Camilla Fröhlich, 
University of Copenhagen, Copenhagen, Denmark), αVβ3 function–
blocking antibody clone LM609 (Chemicon, Temecula, CA), anti-
phosphotyrosine, clone 4G10 (Millipore, Billerica, MA), anti–PI3K 
p85 (Millipore), anti-vinculin (clone hVIN-1; Sigma-Aldrich, St. Louis, 
MO), and anti–human CD148 clone A3 (Biolegend, San Diego, CA). 
The following peptides were obtained from Peptide Protein Research 
(Wickham, United Kingdom): S2CBD, PAIKSTDVYTEKHSDNLF (cor-
responding to P124–F141 of murine SDC-2); S2CBDscr, FPLANIDKSSHT-
KDEVTY (scrambled sequence based on S2CBD); zebS2CBD, 
SIPRPPMDPQDVQSENLF (corresponding to S130–F147 of zebrafish 
SDC-2); and S2CBDala, PAIKSTDVYTEKHSAAAA.
Cells and cell culture
WI38 human lung fibroblasts, rat embryo fibroblasts, fibroblasts 
lacking the Src, Yes, and Fyn kinases, and those with Src restored 
were obtained from the American Type Culture Collection 
(Manassas, VA). All cells were grown and maintained in DMEM 
(Lonza, Basel, Switzerland) supplemented with 10% fetal bovine 
serum (Lonza), 2 mM l-glutamine (Invitrogen, Carlsbad, CA), and 
penicillin (100 U/ml) and streptomycin (100 μg/ml) (Invitrogen). 
For all experiments cells were maintained at 37°C and 10% CO2. 
Primary rat lung fibroblasts were isolated as follows: lungs from 
8-wk-old male C57/Bl6 mice were washed three times in sterile 
phosphate-buffered saline (PBS) before being macerated with a 
scalpel blade. The resultant lung fragments were placed in a 9-cm 
dish in DMEM containing 10% fetal bovine serum (FBS) and main-
tained at 37°C and 10% CO2. The media was routinely changed 
every 2 d. After 10 d, fibroblasts were passaged into 25-cm2 flasks. 
All cells used in this work were p2 or p3.
Fusion proteins and plasmids
The sequence encoding E19–F141 of the murine syndecan-2 extracel-
lular domain was cloned into the bacterial expression vector pET41a 
(Novagen, Gibbstown, NJ) to form an N-terminal GST–mouse syn-
decan-2 fusion protein (S2ED) as described in Whiteford et al. (2007) 
(Figure 1A). On the basis of this vector as template, constructs 
for the expression of syndecan-2 ectodomain mutant GST fusion 
proteins were generated using a PCR-based approach. Briefly, 
primer pairs were designed to generate in-frame deletion mutants 
in which residues E19–Q72 (S2EDΔE19-Q72), P85–F141 (S2EDΔP85-F141), 
P105–F141 (S2EDΔP105-F141), P124-–F141 (S2EDΔP124-F141), and L73–P124 
(S2EDΔL73-P124) were removed from the coding sequence of S2ED 
(Figure 1A; primer sequences are listed in Supplemental Table S2). 
Forward and reverse primer pairs corresponding to each mutant 
were used to PCR amplify S2ED vector DNA, and the resultant PCR 
products were digested with DpnI for 2 h at 37°C. PCR products 
were ethanol precipitated, and the pellets were resuspended in wa-
ter and phosphorylated using T4 polynucleotide kinase. Products 
were then gel purified, ligated, and transformed into Escherichia 
coli using standard procedures. In-frame deletion of regions within 
S2ED was verified by DNA sequencing, and plasmids were trans-
formed into E. coli strain BL21. Transformed bacterial strains were 
grown to an OD600 of 0.5 prior to the addition of 1 ml/l of 1 M 
isopropyl-β-d-thiogalactoside (IPTG) and incubated for a further 3 h. 
2000; Holsinger et al., 2002; Palka et al., 2002; Pera et al., 2005; 
Tsuboi et al., 2008). Phosphorylation of CD148 is not well character-
ized; however, yeast two-hybrid studies demonstrated that the 
CD148 cytoplasmic domain interacts with the p85 subunit of PI3K 
but only occurred in yeast expressing a constitutively active Src ki-
nase (Tsuboi et al., 2008). Fibroblast adhesion to both S2ED and 
cognate CD148 antibodies was compromised in the presence of 
wortmannin, suggestive of a role for PI3K. Class Ia PI3Ks are het-
erodimeric proteins comprising an 85-kDa regulatory unit (p85) and 
a 110-kDa catalytic unit (p110). Under basal conditions the p85–
p110 complex is stabilized by interactions involving the SH2 do-
mains of the p85 subunit, leading to inhibition of PI3K activity. Phos-
phorylation of tyrosine residues within YXXM motifs on receptors 
and adaptor proteins results binding of the SH2 domains of p85, 
resulting in alleviation of p85-mediated inhibition of p110, allowing 
PI3K to phosphorylate its lipid substrates. Interactions between p85 
and the CD148 cytoplasmic domain are likely to be via the CD148 
catalytic site since substrate-trapping mutants of CD148 capture 
p85, and although interactions with phosphotyrosines on the cyto-
plasmic domain may occur, none of the tyrosine residues within the 
cytoplasmic domain of CD148 lie within a YXXM motif (Tsuboi et al., 
2008). The effect of phosphorylation of the p85 subunit on PI3K 
activity is not clear, although there are reports that p85 tyrosine 
phosphorylation can lead to an up-regulation of enzyme activity 
(Cuevas et al., 2001). During the initial phases of adhesion to S2ED 
as attachment and spreading proceeded, we found rapid dephos-
phorylation of p85 followed by rephosphorylation. This did not cor-
relate with a reduction in p85-associated PI3K activity during the 
early phase of adhesion to S2ED (Figure 7C). Our in vitro kinase as-
says reflect total cellular class Ia PI3K activity, and it is possible that 
the effects of p85 dephosphorylation on PI3K activity are only local-
ized to adhesion points and any changes in PI3K are masked by the 
global levels of active kinases within the cell. As adhesion pro-
ceeded, p85 phosphorylation was restored. Use of the PI3K inhibi-
tor GDC-0941 in adhesion to S2ED suggested the involvement of a 
second PI3K family member, PI3K-C2β. This kinase was reported to 
have roles in cell adhesion, migration, and cytoskeletal rearrange-
ments and also influences the expression of β1 integrin (Domin 
et al., 2005; Katso et al., 2006).
Our data demonstrated a requirement for activated Src kinase 
but not the related Yes or Fyn kinases upstream of PI3K in adhesion 
to S2ED. However, c-Src is apparently not a substrate for CD148/
PTPRJ during this process, although CD148 has been reported to 
dephosphorylate the Tyr-527 residue, leading to up-regulated Src 
kinase activity (Pera et al., 2005). An alternative hypothesis is that Src 
kinase is required for phosphorylation of the cytoplasmic domain of 
CD148, which could be a necessary regulatory step for the phos-
phatase activity. Its cytoplasmic domain consists of 341 residues 
comprising a single phosphatase domain and a canonical class II 
PDZ binding motif at its C-terminus. Contained within this sequence 
are 20 tyrosine, 19 serine, and 24 threonine residues, many of which 
are potential sites of phosphorylation. It is also conceivable that Src 
is required for the phosphorylation of p85 after the initial phases of 
adhesion to S2ED.
Fibroblast adhesion to the syndecan-2 extracellular core protein 
can be compromised using β1 integrin–blocking antibodies, but we 
showed that S2ED is not an integrin ligand. The data demonstrate 
that cross-talk between cell surface receptors, in this case CD148 
and β1 integrin in response to syndecan-2, can lead to cell adhesion 
responses. Integrins are vital for many aspects of cell behavior, in-
cluding adhesion, migration, survival, proliferation, and cell fate. 
The pathway described here provides evidence for a novel role of 
3622 | J. R. Whiteford et al. Molecular Biology of the Cell
Bacterial pellets were lysed using rLysozyme (Novagen, Gibbstown, 
NJ) as described by the manufacturer. Fusion proteins were purified 
using glutathione–Sepharose 4B (GE Healthcare, Piscataway, NJ) as 
described previously (Whiteford and Couchman, 2006).
The sequence encoding the first five N-terminal FN type III re-
peats of the extracellular domain of human CD148 was cloned into 
the BamHI/HindIII sites of the bacterial expression vector pET24 
(Novagen) using standard procedures, and the resultant vector was 
transformed into E. coli strain BL21. The primers used are described 
in the supplemental figures. Bacteria were grown to an OD600 of 
0.5 at 37°C prior to the addition of 1 ml/l 100 mM IPTG and incu-
bated for a further 5 h at 30°C. Recombinant CD148 extracellular 
domain protein was purified using His-Select Nickel Affinity Gel 
(Sigma-Aldrich) as described by the manufacturer.
Expression constructs encoding full-length avian wild-type c-Src 
(c-Src-WT) and constitutively active c-Src (c-Src-CA, Y527F point mu-
tation) were previously described (Sanjay et al., 2001; Destaing 
et al., 2008) and were a generous gift from Marie Kveiborg (Univer-
sity of Copenhagen). cSrc inserts were excised using ClaI and NotI 
and the ends filled in using Klenow polymerase prior to ligation into 
the SmaI site of pIRES2–enhanced green fluorescent protein (eGFP; 
Clontech, Mountain View, CA) using standard procedures. The ori-
entation of inserts was verified by restriction digest, and cells were 
transfected using lipofectamine as per the manufacturer’s protocol. 
The mammalian expression pCMV-SPORT6 containing full-length 
cDNAs for murine Src, Yes, and Fyn were obtained from ImaGenes 
(Nottingham, United Kingdom).
Adhesion assays
Substrates included GST, S2ED, and the mutated forms of S2ED 
described earlier and anti-CD148 antibody (clone A3; Biolegend). 
Plates (24 well) were coated overnight with 2.5 μg of each substrate 
at 4°C. Wells were then washed with PBS prior to the addition of 
1% BSA in PBS for 1 h at 37ºC. Adherent cells were detached with 
trypsin (Invitrogen), and cell suspensions were prepared using me-
dia containing FBS to inactivate the protease. Cells were pelleted 
by centrifugation and washed twice in serum-free media, then 
seeded at 2 × 105 per ml of medium and incubated for 60 min at 
37ºC. Wells were washed gently with PBS prior to fixation in 0.25 ml 
of 4% PFA (paraformaldehyde) in PBS for 10 min. Fixed cells were 
washed three times with PBS and were stained with 0.1% crystal 
violet in 10% methanol for 20 min at room temperature. Wells were 
washed three times under running water to remove excess stain 
before the addition of 0.25 ml/well of PBS and 10 μl of 10% SDS. 
Plates were shaken gently for 5 min before the OD was measured 
at 590 nm. In antibody-blocking experiments, cell suspensions in 
serum-free media were incubated at 4ºC for 15 min in the presence 
or absence of 40 μg/ml antibody prior to seeding onto substrates. 
Phosphatase inhibitors, Src inhibitors, peptides, and wortmannin 
(Calbiochem, La Jolla, CA) and GDC-0941 were added prior to cell 
seeding as described earlier. Sodium pervanadate (1 mM) was pre-
pared as described in Ott and Rapraeger (1998). Phenylarsine ox-
ide and dephostatin were used at 10 and 5 μM, respectively. Src 
inhibitors were used at the following concentrations; Src kinase in-
hibitor I, 75 nM (Calbiochem); SU6656, 200 nM (Calbiochem), and 
PP1, 1 μM (Merck, Darmstadt, Germany). Neuraminidase from 
Clostridium perfringens was obtained from New England Biolabs 
(Ipswich, MA) and used at a concentration of 50 U/ml.
Flow cytometry
Suspensions of adherent cells were prepared using enzyme-free cell 
dissociation buffer (Invitrogen) and were washed twice in PBS with 
1% normal goat serum (NGS; Invitrogen) and incubated at 4ºC for 
30 min in the presence of primary antibodies as directed by the 
manufacturer. Cells were washed twice in PBS with 1% NGS prior to 
incubation at 4ºC for 30 min with the appropriate Alexa Fluor 
488–conjugated secondary antibody. After two washes with PBS and 
1% NGS, cell populations were analyzed using a BD FACSCalibur 
flow cytometer (BD Biosciences, Oxford, United Kingdom) and the 
flow cytometry analysis software FlowJo (Tree Star, Ashland, OR).
Transfection of Wi38 cells with gene-specific CD148 siRNAs
WI38 cells were transfected with siRNAs using the HiPerfect 
reagent (Qiagen, Valencia, CA). The following CD148 gene-
specific siRNA sequences were obtained from Qiagen: rj1, 
[r(UUGAUUGUAGAAGAUACGG)dGdT], SI00044268; and rj2, 
[r(UAUAGUUAGAUGACGACUC)dGdT], SI00044275. WI38 cells 
(8 × 104/well) were seeded in a six-well plate for 48 h and then 
transfected with siRNA pairs (rj1 and rj2) and the AllStars Negative 
Control siRNA (Qiagen), using each siRNA at the concentration 
indicated, in conjunction with 5 μl of HiPerfect reagent as de-
scribed in the manufacturer’s instructions. The effects of siRNA 
treatments on cell surface levels of CD148 were analyzed by FACS 
48 h after transfection.
Solid-phase binding assay
Microtiter plate wells were coated overnight with 200 ng of S2ED, 
S4ED, GST, or the S2ED mutants in PBS prior to blocking in 1% BSA 
in PBS for 1 h at room temperature. Wells were washed three times 
with PBS, after which twofold serial dilutions of CD148sf (highest 
concentration, 200 ng/ml) was added, and left at room temperature 
for 2 h. Wells were washed three times with PBS, and the plate was 
incubated with anti-CD148 (clone A3) antibodies (diluted 1:2500 in 
PBS) for 1 h at room temperature. Wells were washed as described 
prior to the addition of rabbit anti–mouse immunoglobulin G (IgG) 
conjugated to horseradish peroxidase (diluted 1:5000 in PBS; Dako, 
Glostrup, Denmark). After five washes with PBS, TMB One solution 
(Promega, Madison, WI) was added to each well and the reactions 
stopped by the addition of 0.1 M hydrochloric acid. The absorbance 
of each well was measured at 450 nm.
Phase-contrast and immunofluorescence microscopy
Phase-contrast micrographs were captured on an Olympus (Center 
Valley, PA) IX81 microscope with a Hamamatsu (Hamamatsu, Japan) 
ORCA-ER digital camera and processed using the Cell software 
from Olympus and Adobe Photoshop (San Jose, CA). Fibroblasts 
were immunostained for vinculin and F-actin as described previously 
(Whiteford et al., 2007). For confocal analysis, the cells were scanned 
using a Zeiss LSM 5 PASCAL confocal laser-scanning microscope 
(Zeiss, Welwyn Garden City, United Kingdom) with a 20× (numerical 
aperture [NA] 0.5 W, PH2) or 40× (NA 0.75 W, PH2) water-dipping 
Achroplan objective.
immunoprecipitation and Pi3K activity assay
Immunoprecipitation of the p85 subunit of PI3K was performed 
as follows. Cells were lysed at the time points indicated in buffer 
(20 mM Tris HCl, pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 0.1 mM eth-
ylene glycol tetraacetic acid, 1% Triton X-100, and 1× Halt protease 
and phosphatase inhibitor cocktail [Thermo Scientific, Waltham, 
MA]) and centrifuged at 15,000 × g for 20 min at 4ºC. Immunopre-
cipitation of the p85 subunit of PI3K was performed on lysates using 
EZ view protein A agarose and specific antibodies as described by 
the manufacturer (Sigma-Aldrich). For PI3K activity assays, p85 im-
munoprecipitations were performed as described, and complexes 
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